#regulatory innovation

The FDA just picked its first company to sell an unauthorised device to Medicare patients

The FDA has selected Dexcom as the first company to offer an unapproved device to Medicare patients under its new TEMPO pilot program, using enforcement discretion to accelerate access to digital health innovations.